top of page

Why is a curable disease allowed to kill millions?

resisttb

John Green, the author of several books and a longtime supporter of Partners in Health, discusses his time visiting Sierra Leone’s Lakka Government Hospital, a tuberculosis treatment center. He talks about Henry, a 16-year old boy cured from multi-drug resistant TB as the first Sierra Leonean patient to receive a newly designed treatment regimen that included bedaquiline in 2021. With J&J's patent on bedaquiline ending soon, John Green provides us with a call to action to urge J&J to relinquish its extended patent claims and make the drug more widely accessible and affordable. Read more here.

49 views0 comments

Recent Posts

See All

Armand Van Deun Scholarship Initiative

The Institute of Tropical Medicine has announced two initiatives to honor the legacy of Armand Van Deun: a new meeting room in his name...

Comentários


bottom of page